IHH Annual Report 2023

Impact of Value Creation At IHH Healthcare, our year-on-year growth, success and repute have only been possible through our proactive value generation for all our stakeholders. To us, value transcends share price and earnings, taking into account the interests of our diverse stakeholder groups. Cultivating a healthcare ecosystem that is sustainable is how we generate the highest benefit for our patients, employees, shareholders and the public. The following segment highlights how we have created value for our stakeholders in 2023. Total Shareholder Value – also known as ‘Return on Shareholders’ Funds (excluding exceptional items)’ – of 4.63% based on FY2023 348 investor meetings held 13 conferences and NDR attended 8awards won Investors and Shareholders The support from our investors and shareholders is pertinent to IHH’s share price performance. We regularly keep this stakeholder group abreast of all IHH financial updates and corporate developments, and proactively forge positive relationships for the long run. Total dividend of 18.6 sen declared for FY2023, comprising interim cash dividend of 3.5 sen, special dividend of 9.6 sen and a final cash dividend of 5.5 sen For more information refer to Investor Relations Report on page 119. 500 free radiotherapy and radiosurgery sessions, through IHH Malaysia’s hospital network, to help the underserved patients Patients We take pride in ensuring that patients receive trusted high-quality care with our exceptional clinical teams, fast-expanding facilities and swift services. We deliver optimal performance keeping sustainable practices in mind. 16 new facilities across all markets were launched Our Value-Driven Outcomes (VDO) programme has expanded to include 157 conditions, up from 113 in 2022 For more information on our sustainability initiatives, please refer to page 60. IHH Healthcare Berhad 34 Strategic Report

RkJQdWJsaXNoZXIy NDgzMzc=